110
Participants
Start Date
February 28, 2013
Primary Completion Date
December 14, 2018
Study Completion Date
December 20, 2019
Human cl rhFVIII
All Children's Hospital, St. Petersburg
University Hospital Frankfurt/M, Frankfurt
UC Davis, Sacramento
Harvard Children's Hospital Boston, Boston
Republican Scientific Practical Center for Pediatric Oncology and Hematology, Minsk
L'hôpital Côte de Nacre - CHU de Caen, Caen
Centre de traitement de l'hemophilie, Hôpital Bicêtre, Le Kremlin-Bicêtre
Hopital de la Timone, Marseille
Hôtel-Dieu de Nantes, Centre Regional de Traitement de l'hemophilie, Nantes
Hôpital Necker, Paris
CHU de Rennes - Hôpital Pontchaillou, Rennes
Hopital Trousseau - CHU Tours, Tours
Institute of Haematology and Transfusiology, Tbilisi
Institut für Experimentelle Hämatologie und Transfusionsmedizin (IHT), Bonn
Universitätsmedizin der Johannes-Gutenberg-Universität Mainz, Mainz
Kasturba Medical College, Dr. TMA Pai Hospital, Manipal
Sahyadri Speciality Hospital, Haematology & BMT Unit, Pune
Christian Medical College & Hospital, Dept of Haematology, Vellore
Univ. Di Perugia, Perugia
Centro di Referimento per le Malattie Emorragiche e Trombotiche, Torino
Scientific Research Institute of Mother and Child Health Care, Chisinau
Centre Hospitalier Ibn Sina, Rabat
HSJ - Hospital de São João, EPE, Porto
Morozovsky Children's Hospital, Moscow
Haemophilia Centre, University Clinical Centre, Ljubljana
Unitat d'hemofilia, Hospital Universitari Vall d'Hebron, Barcelona
Hospital Universitario La Paz, Madrid
"National Children's Specialized Hospital OHMATDET", Kiev
Institute of Blood Pathology and Transfusion Medicine, Lviv
University of Alberta, Edmonton
BC Children's Hospital, Vancouver
Mc Master Children's Hospital, Hamilton
Hospital for Sick Children, Toronto
Hopital Ste-Justine, Montreal
University Medical School Warsaw, Warsaw
Cambridge University Hospital, Cambridge
Great Ormond Street Hospital for Children, London
Lead Sponsor
Octapharma
INDUSTRY